tirzepatide and pancreatitis Fatal, Fulminant, Necrotizing Associated With Recent Initiation Compounded Tirzepatide Weight Loss Program

In comparison to other GLP-1RAs, semaglutide was found to produce up to three times higher weight loss in type 2 diabetic patients and up to twice as much weight loss in obese patients, with some patients losing up to 15 kg

EXSCEL (Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes) revealed that the incidence of major cardiovascular events was not significantly different in the group receiving exenatide compared to placebo

The Association of Moisture Intake and Constipation Among US Adults: Evidence From NHANES 2005-2010

Lancet 378:182197 Madsbad S, Holst JJ (2014) GLP-1 as a mediator in the remission of type 2 diabetes after gastric bypass and sleeve gastrectomy surgery